Transcat’s (TRNS) “Buy” Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Transcat (NASDAQ:TRNS) in a report issued on Tuesday morning, Benzinga reports. They currently have a $156.00 price target on the scientific and technical instruments company’s stock. HC Wainwright also issued estimates for Transcat’s Q3 2025 earnings at $0.43 EPS, Q4 2025 earnings at $0.63 EPS and FY2025 earnings at $1.98 EPS.

A number of other research analysts also recently issued reports on the company. Oppenheimer boosted their price objective on Transcat from $125.00 to $160.00 and gave the company an outperform rating in a research note on Wednesday, May 22nd. Northland Capmk lowered Transcat from a strong-buy rating to a hold rating in a research note on Wednesday, May 22nd. Finally, Northland Securities downgraded shares of Transcat from an outperform rating to a market perform rating in a research report on Wednesday, May 22nd. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of Moderate Buy and a consensus target price of $151.33.

Transcat Stock Down 3.1 %

NASDAQ:TRNS opened at $107.60 on Tuesday. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.14 and a quick ratio of 2.62. Transcat has a one year low of $84.45 and a one year high of $147.12. The firm’s 50 day simple moving average is $126.19 and its 200 day simple moving average is $115.80. The company has a market cap of $983.46 million, a PE ratio of 67.67 and a beta of 0.68.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings data on Monday, July 29th. The scientific and technical instruments company reported $0.48 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.20. The company had revenue of $66.70 million during the quarter, compared to analysts’ expectations of $69.35 million. Transcat had a net margin of 5.69% and a return on equity of 9.23%. Transcat’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.38 earnings per share. On average, research analysts anticipate that Transcat will post 2.06 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Lee D. Rudow sold 3,343 shares of the business’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $124.12, for a total transaction of $414,933.16. Following the completion of the sale, the chief executive officer now owns 103,692 shares in the company, valued at $12,870,251.04. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, insider James M. Jenkins sold 5,514 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $137.18, for a total value of $756,410.52. Following the transaction, the insider now owns 1,619 shares of the company’s stock, valued at approximately $222,094.42. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Lee D. Rudow sold 3,343 shares of the business’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $124.12, for a total value of $414,933.16. Following the sale, the chief executive officer now directly owns 103,692 shares of the company’s stock, valued at $12,870,251.04. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 22,215 shares of company stock worth $2,969,084. Corporate insiders own 4.20% of the company’s stock.

Institutional Investors Weigh In On Transcat

Several institutional investors have recently bought and sold shares of TRNS. First Horizon Advisors Inc. lifted its stake in Transcat by 26.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock valued at $72,000 after acquiring an additional 125 shares in the last quarter. Fifth Third Bancorp boosted its holdings in Transcat by 95.8% during the second quarter. Fifth Third Bancorp now owns 656 shares of the scientific and technical instruments company’s stock worth $79,000 after purchasing an additional 321 shares during the last quarter. Hamilton Wealth LLC bought a new stake in Transcat in the 1st quarter worth about $212,000. Virtu Financial LLC purchased a new stake in Transcat in the 1st quarter valued at about $224,000. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of Transcat by 13.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,347 shares of the scientific and technical instruments company’s stock worth $262,000 after buying an additional 284 shares in the last quarter. Institutional investors own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.